Skip to content
Neuralink logo — Neuralink is developing ultra-high bandwidth brain-machine i...

Neuralink

Neuralink is developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

Founded 2016 United States Fremont, United States 674 employees Series E Total: $1.35B Biotechnology, Robotics

General Information

Company Name Neuralink
Founded Year 2016
Location United States Fremont, United States
Employees 674
Industries Biotechnology, Robotics
Funding Stage Series E

BounceWatch is an independent company data service, not affiliated with Neuralink. To contact Neuralink, visit neuralink.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neuralink compare?

A PDF of Neuralink and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neuralink soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

In The News Oct 08, 2026

Featured on Wired: How Massive Is Elon Musk’s Trillion-Dollar Fortune? Spend It Yourself

About Neuralink

Neuralink is a biotechnology and robotics startup founded in 2016 with the objective of developing ultra-high bandwidth brain-machine interfaces to connect humans and computers. Their slogan, "Neuralink is developing ultra-high bandwidth brain-machine interfaces to connect humans and computers," encapsulates their ambitious vision. The company comprises a team of exceptionally talented individuals dedicated to building devices that can assist people with paralysis and inventing new technologies to expand human capabilities. The ultimate goal is to create a system with at least two orders of magnitude more communication channels (electrodes) than current clinically-approved devices, ensuring safety, and enabling fully wireless communication through the skin. Their most recent achievement was securing a $323.24M Series D investment on 07 August 2023 from Founders Fund, reaffirming the confidence investors have in their vision and potential. Neuralink's headquarters is located in the United States. The company's groundbreaking device, called the Link, is designed to have the capability to record from 1024 electrodes, meeting the aforementioned criteria. With their recent investment, Neuralink is poised to play a significant role in revolutionizing the biotechnology and robotics space, positioning themselves as a key player in the future of brain-machine interfaces.

Business keywords: Neuralink, brain-machine interfaces, neurotechnology, technology innovation, biomedical engineering, neuroscience, paralysis treatment, communication technology, electrode technology, wireless communication, neurological disorders, innovative healthcare, medical advancements

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Series E $650.00M 11
Founders Fund, Lightspeed Venture Partners +9
01 Jun 2025
Secondary Market Undisclosed 1
Bull & Bear, LP
01 Dec 2023
Series C $323.00M 1
Founders Fund
01 Aug 2023
Round Undisclosed -
01 Jan 2023
Secondary Market $10.00M 1
Vika Ventures
01 Jul 2022
Secondary Market Undisclosed -
01 Dec 2021
Series C $205.00M 12
Craft Ventures, Founders Fund +10
01 Jul 2021
Series B $51.00M 1
Elon Musk
01 Apr 2019
Series A $107.00M 1
Elon Musk
01 Aug 2017

Neuralink Alternatives & Competitors

Neuralink vs
HCD Research
HCD Research United States

We employ innovative research tools, comprehensive data collection techniques, & well-honed interpre...

32 employees
Biotechnology, Health Care
Neuralink vs
Satoris Inc.
Satoris Inc. United States

Satoris is a privately held company founded in 2003 with the mission of developing and commercializi...

Series B
3 employees
Biotechnology, Health Care

FAQ About Neuralink

Neuralink is developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.
Neuralink was founded in 2016.
Neuralink is headquartered in Fremont, United States.
Neuralink operates in Biotechnology and Robotics. Its work centres on Neuralink, brain-machine interfaces, neurotechnology and technology innovation.
Neuralink has approximately 674 employees.
Neuralink has completed 9 funding rounds, raising a total of $1.35B. The latest funding stage is Series E.
Top alternatives and competitors to Neuralink include HCD Research, Satoris Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neuralink and HCD Research are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neuralink, https://bouncewatch.com/company/neuralink, updated 20 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout